EyePoint Pharmaceuticals Inc
EYPT13.300USD
+0.570+4.48%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
925.28M시가총액
손실P/E TTM
자세한 내용은 EyePoint Pharmaceuticals Inc 회사
EyePoint Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing innovative therapeutics to help improve the lives of patients with serious retinal diseases. The Company’s lead product candidate, DURAVYU, is an investigational sustained delivery treatment for anti-vascular endothelial growth factor (anti-VEGF) mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E. DURAVYU is presently in Phase 3 global, pivotal clinical trials for wet age-related macular degeneration (wet AMD). Additional pipeline programs include EYP-2301, a promising TIE-2 agonist, razuprotafib, formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The Company’s other products include YUTIQ and DEXYCU.
EyePoint Pharmaceuticals Inc 정보
종목 코드 EYPT
회사 이름EyePoint Pharmaceuticals Inc
상장일Jan 27, 2005
CEODuker (Jay S)
직원 수165
유형Ordinary Share
회계 연도 종료Jan 27
주소480 Pleasant Street, Suite C400
도시WATERTOWN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02472
전화16179265000
웹사이트https://eyepointpharma.com/
종목 코드 EYPT
상장일Jan 27, 2005
CEODuker (Jay S)
EyePoint Pharmaceuticals Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Jay S. Duker, M.D.
Dr. Jay S. Duker, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
753.40K
+67787.00%
Ms. Nancy S. Lurker
Ms. Nancy S. Lurker
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
653.26K
+87799.00%
Dr. John B. Landis, Ph.D.
Dr. John B. Landis, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
142.86K
+121464.00%
Ms. Karen L. Zaderej
Ms. Karen L. Zaderej
Non-Executive Independent Director
Non-Executive Independent Director
117.28K
+2000.00%
Mr. Stuart Duty
Mr. Stuart Duty
Non-Executive Independent Director
Non-Executive Independent Director
45.01K
+45014.00%
Mr. Ramiro Ribeiro, M.D., Ph.D.
Mr. Ramiro Ribeiro, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
39.06K
--
Dr. Goeran A. Ando, M.D.
Dr. Goeran A. Ando, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Ms. Wendy F. Dicicco, CPA
Ms. Wendy F. Dicicco, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. George Elston
Mr. George Elston
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Stern
Mr. Stern
Investor Relations
Investor Relations
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Jay S. Duker, M.D.
Dr. Jay S. Duker, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
753.40K
+67787.00%
Ms. Nancy S. Lurker
Ms. Nancy S. Lurker
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
653.26K
+87799.00%
Dr. John B. Landis, Ph.D.
Dr. John B. Landis, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
142.86K
+121464.00%
Ms. Karen L. Zaderej
Ms. Karen L. Zaderej
Non-Executive Independent Director
Non-Executive Independent Director
117.28K
+2000.00%
Mr. Stuart Duty
Mr. Stuart Duty
Non-Executive Independent Director
Non-Executive Independent Director
45.01K
+45014.00%
Mr. Ramiro Ribeiro, M.D., Ph.D.
Mr. Ramiro Ribeiro, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
39.06K
--
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2024
FY2023
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
YUTIQ
3.10M
7.16%
지역별USD
이름
수익
비율
United States
42.05M
97.17%
China
1.12M
2.60%
United Kingdom
100.00K
0.23%
사업별
지역별
사업별USD
이름
수익
비율
YUTIQ
3.10M
7.16%
주식 보유 통계
마지막 업데이트: Mon, Nov 17
마지막 업데이트: Mon, Nov 17
주주
주주 유형
주주
주주
비율
Cormorant Asset Management, LP
9.98%
Suvretta Capital Management, LLC
7.48%
Adage Capital Management, L.P.
6.72%
The Vanguard Group, Inc.
5.82%
BlackRock Institutional Trust Company, N.A.
5.17%
기타
64.82%
주주
주주
비율
Cormorant Asset Management, LP
9.98%
Suvretta Capital Management, LLC
7.48%
Adage Capital Management, L.P.
6.72%
The Vanguard Group, Inc.
5.82%
BlackRock Institutional Trust Company, N.A.
5.17%
기타
64.82%
주주 유형
주주
비율
Hedge Fund
32.77%
Investment Advisor
25.05%
Investment Advisor/Hedge Fund
20.85%
Research Firm
4.43%
Private Equity
3.39%
Individual Investor
2.96%
Venture Capital
2.58%
Bank and Trust
1.06%
Pension Fund
0.13%
기타
6.79%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
363
69.86M
126.07%
--
2025Q3
373
69.94M
127.01%
+1.23K
2025Q2
381
69.95M
127.71%
-5.27M
2025Q1
371
75.32M
126.89%
-11.89M
2024Q4
359
75.24M
109.81%
+11.20M
2024Q3
343
59.71M
126.62%
+193.11K
2024Q2
330
60.06M
120.79%
+1.75M
2024Q1
313
56.72M
108.78%
+2.51M
2023Q4
268
50.21M
76.86%
+16.41M
2023Q3
224
33.81M
98.97%
+2.98M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Cormorant Asset Management, LP
8.27M
9.98%
-60.00K
-0.72%
Dec 04, 2025
Suvretta Capital Management, LLC
6.19M
7.48%
-611.38K
-8.99%
Sep 30, 2025
Adage Capital Management, L.P.
5.56M
6.72%
-1.24M
-18.24%
Sep 30, 2025
The Vanguard Group, Inc.
3.79M
4.58%
-8.13K
-0.21%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.28M
5.17%
-316.39K
-6.88%
Sep 30, 2025
Franklin Advisers, Inc.
4.14M
5%
-130.85K
-3.07%
Sep 30, 2025
Federated Hermes Global Investment Management Corp.
3.58M
4.32%
-1.46K
-0.04%
Sep 30, 2025
TCG Crossover Management, LLC
3.57M
4.32%
--
--
Sep 30, 2025
Citadel Advisors LLC
2.14M
2.58%
-208.82K
-8.91%
Sep 30, 2025
Paradigm BioCapital Advisors LP
2.01M
2.42%
+2.01M
--
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Virtus LifeSci Biotech Clinical Trials ETF
1%
Simplify Health Care ETF
0.99%
State Street SPDR S&P Pharmaceuticals ETF
0.98%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.95%
Invesco Dorsey Wright SmallCap Momentum ETF
0.36%
Federated Hermes MDT Small Cap Core ETF
0.3%
iShares Micro-Cap ETF
0.15%
iShares Health Innovation Active ETF
0.15%
ProShares Ultra Nasdaq Biotechnology
0.12%
Invesco Nasdaq Biotechnology ETF
0.09%
더 보기
Virtus LifeSci Biotech Clinical Trials ETF
비율1%
Simplify Health Care ETF
비율0.99%
State Street SPDR S&P Pharmaceuticals ETF
비율0.98%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
비율0.95%
Invesco Dorsey Wright SmallCap Momentum ETF
비율0.36%
Federated Hermes MDT Small Cap Core ETF
비율0.3%
iShares Micro-Cap ETF
비율0.15%
iShares Health Innovation Active ETF
비율0.15%
ProShares Ultra Nasdaq Biotechnology
비율0.12%
Invesco Nasdaq Biotechnology ETF
비율0.09%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
날짜
배당락일
유형
비율
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
